Human depression: A new approach in quantitative psychiatry

Annals of General Psychiatry

Volumn 9, Issue , 2010, Pages

  Cocchi, Massimo ^a,b   Tonello, Lucio ^a,b   Rasenick, Mark M ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b L U de S University   (Switzerland)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GS ALPHA PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ARTIFICIAL NEURAL NETWORK; CELL MEMBRANE; CONSCIOUSNESS; ELECTROENCEPHALOGRAM; HUMAN; HYPOTHESIS; MAJOR DEPRESSION; REVIEW; VISCOSITY;

EID: 77952979625     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-9-25     Document Type: Review

References (44)

1. Cocchi M, Tonello L, Tsaluchidu S, Puri BK. The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatry 2008, 8(Suppl 1):S3. 10.1186/1471-244X-8-S1-S3, 2330078, 18433513.
2. Coleman M. Platelet serotonin in disturbed monkeys and children. Clin Proc Children's Hospital 1971, 27:187-194.
3. Takahashi S. Reduction of blood platelet serotonin levels in manic and depressed patients. Folia Psychiatr Neurol Jpn 1976, 30:475-486.
4. Sthal SM. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 1977, 34:509-516.
5. Kim HL, Plaisant O, Leboyer M, Gay C, Kamal L, Devynck MA, Meyer P. Reduction of platelet serotonin in major depression (endogenous depression). C R Seances Acad Sci III 1982, 295:619-622.
6. Dreux C, Launay JM. Blood platelets: neuronal model in psychiatric disorders. Encephale 1985, 11:57-64.
7. Arora RC, Meltzer HY. Increased serotonin 2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 1989, 44:725-734. 10.1016/0024-3205(89)90384-6, 2927243.
8. Thompson P. Platelet and erythrocyte membrane and fluidity changes in alcohol dependent patients undergoing acute withdrawal. Alcohol Alcoholism 1999, 3:349-354.
9. Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med 2000, 62:326-336.
10. Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness. Clin Exp Pharmacol 2001, 16:229-236.
11. Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern 1982, 43:59-69.
12. Kohonen T. Self-Organizing Maps. 2001, Berlin, Germany: Springer, 3.
13. Kohonen T, Kaski S, Somervuo P, Lagus K, Oja M, Paatero V. Self-organizing map. Neurocomputing 1998, 21:113-122.
14. Bowden CL. Strategies to reduce misdiagnosis of bipolar depression. Psychiatr Serv 2001, 52:51-55. 10.1176/appi.ps.52.1.51, 11141528.
15. Donati RJ, Dwivedi Y, Roberts RC, Conley RR, Pandey GN, Rasenick MM. Postmortem brain tissue of depressed suicides reveals increased Gs localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci 2008, 28:3042-3050. 10.1523/JNEUROSCI.5713-07.2008, 18354007.
16. Hameroff SR, Penrose R. Orchestrated reduction of quantum coherence in brain microtubules: a model for consciousness. Toward a Science of Consciousness - The First Tucson Discussions and Debates 1996, 507-540. Cambridge, MA, USA: MIT Press, Hameroff SR, Kaszniak A, Scott AC.
17. Hameroff SR. The "conscious pilot"-dendritic synchrony moves through the brain to mediate consciousness. J Biol Phys 2010, 36:71-93. 10.1007/s10867-009-9148-x, 2791805,2791805, 19669425.
18. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J. Molecular Biology of the Cell 1994, Garland Science Publishing, New York and Oxford.
19. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 1994, 633:297-304. 10.1016/0006-8993(94)91552-0, 8137164.
20. Pacheco MA, Stockmeier C, Meltzer HY, Overholser JC, Dilley GE, Jope RS. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 1996, 723:37-45. 10.1016/0006-8993(96)00207-7, 8813380.
21. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999, 73:1121-1126. 10.1046/j.1471-4159.1999.0731121.x, 10461903.
22. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue. Brain Res Bull 2001, 55:625-629. 10.1016/S0361-9230(01)00524-X, 11576759.
23. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology 2002, 27:499-517.
24. Dwivedi Y, Rizavi HS, Shukla PK, Lyons J, Faludi G, Palkovits M, Sarosi A, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 2004, 55:234-243. 10.1016/j.biopsych.2003.11.003, 14744463.
25. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Mondal AC, Shukla PK, Conley RR. Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 2005, 30:1548-1556. 10.1038/sj.npp.1300765, 15920506.
26. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signaling. Nature Rev Neurosci 2007, 8:128-140.
27. Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol Psychiatry 1988, 23:543-559. 10.1016/0006-3223(88)90002-9, 2833319.
28. Garcia-Sevilla JA, Padro D, Giralt MT, Guimon J, Areso P. Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch Gen Psychiatry 1990, 47:125-132.
29. Pandey GN, Pandey SC, Davis JM. Peripheral adrenergic receptors in affective illness and schizophrenia. Pharmacol Toxicol 1990, 66:13-36. 10.1111/j.1600-0773.1990.tb02071.x, 2179928.
30. Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990, 28:215-222. 10.1016/0006-3223(90)90576-N, 2378926.
31. Menninger JA, Tabakoff B. Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression. Biol Psychiatry 1997, 42:30-38. 10.1016/S0006-3223(96)00245-4, 9193739.
32. Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry 1998, 43:574-583. 10.1016/S0006-3223(97)00327-2, 9564442.
33. Menninger JA, Barón AE, Conigrave KM, Whitfield JB, Saunders JB, Helander A, Eriksson CJ, Grant B, Hoffman PL, Tabakoff B. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. Alcohol Clin Exp Res 2000, 24:810-821. 10.1111/j.1530-0277.2000.tb02060.x, 10888069.
34. Hines LM, Tabakoff B. Platelet adenylyl cyclase activity: a biological marker for major depression and recent drug use. Biol Psychiatry 2005, 58:955-962. 10.1016/j.biopsych.2005.05.040, 16095566.
35. Flynn G, Alexander D, Harris A, Whitford T, Wong W, Galletly C, Silverstein S, Gordon E, Williams LM. Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophr Res 2008, 105:262-271. 10.1016/j.schres.2008.05.029, 18603413.
36. Cocchi M, Tonello L. Running the hypothesis of a biomolecular approach to psychiatric disorder characterization and fatty acids therapeutical choices. Ann Gen Psychiatry 2010, 9(Suppl 1):S26.
37. Mullis KB. Interview by Marco Pivato. Ma la depressione è nel sangue. Newspaper: La Stampa, insert: TuttoScienze 2008, 5.
38. Hameroff SR. Interview by Marco Pivato. Ma la depressione è nel sangue. Newspaper: La Stampa, insert: TuttoScienze 2008, 5.
39. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122. 10.1146/annurev.neuro.22.1.105, 10202533.
40. Duman SR, Malberg J, Nagakawa S, D'Sa C. Neuronal plasticity and survival in mood disorder. Biol Psychiatry 2000, 48:732-739. 10.1016/S0006-3223(00)00935-5, 11063970.
41. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000, 14:139-151. 10.1177/026988110001400203, 10890308.
42. Bianchi M, Heidbreder C, Crespi F. Cytoskeletal changes in the hippocampus following restraint stress: Role of serotonin and microtubules. Synapse 2003, 49:188-194. 10.1002/syn.10230, 12774303.
43. Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci 1980, 77:7463-7467. 10.1073/pnas.77.12.7463, 350524, 6938985.
44. Popova JS, Greene AK, Wang J, Rasenick MM. Phosphatidylinositol 4, 5-bisphosphate modifies tubulin participation in phospholipase Cβ1 signaling. J Neurosci 2002, 22:1668-1678.